Follow-Up of Pregnancy in Acromegalic Women: Different Presentations and Outcomes

Abstract

Pregnancy in acromegaly is a rather rare event since the fertility is reduced in acromegalic women. Besides, metabolic complications of acromegaly are harmful to both mother and fetus. Little is known about the outcome of pregnancy in acromegalic women. Here, we report seven cases of pregnancy out of 48 acromegalic women followed for 16 years. At diagnosis, five patients had macroadenoma, one patient had microadenoma and the size of the tumor was not documented in one patient. In one patient, acromegaly was initially diagnosed during pregnancy at 29 weeks. When she was 33 weeks, she developed pituitary apoplexy and had an emergency transsphenoidal resection of her macroadenoma during which she also had a cesarian section and delivered a healthy baby girl. In the remaining six patients, pregnancy occured 6 to 64.5 months after the adenoma resection. Three patients received radiotherapy before getting pregnant. In three patients, pregnancy occured during bromocriptine treatment and the drug was withdrawn. In one patient, pregnancy occured during chronic octreotide treatment and therapeutic abortion was performed. In another patient, therapeutic abortion was performed because of uncontrolled disease. In the remaining four patients, there were neither worsening of symptoms nor tumor growth. All four patients gave birth to full-term healthy infants. Out of our seven patients, two developed gestational diabetes mellitus which was controlled with diet. None of the patients had coronary artery disease, hypertension or dyslipidemia. These cases show that pregnancy might be uneventful in acromegalic women when the disease is controlled with prior surgery and radiotherapy.

Acromegaly - pregnancy - pituitary apoplexy - octreotide - bromocriptine

References

• 1 Aso T, Goto K, Takeuchi J, Kotsuji F, Tominaga T. A triplet pregnancy after gonadotropin-releasing hormone pulsatile infusion therapy in a postoperative case of growth hormone-producing pituitary macroadenoma.  Endocrinol Japon. 1987;  34 395-405
• 2 Beckers A, Stevenaert A, Foidart J M, Hennen G, Frankenne F. Placental and pituitary growth hormone secretion during pregnancy in acromegalic women.  J Clin Endocrinol Metab. 1990;  71 725-731
• 3 Braat D DM, Veersema S, Assies J, Schoemaker J. Triplet pregnancy after pulsatile gonadotrophin-releasing hormone treatment in an acromegalic woman.  Eur J Obstet Gynecol Reprod Biol. 1994;  54 148-149
• 4 Bronstein M D, Salgado L R, de Castro Musolino N R. Medical management of pituitary adenomas: the special case of the pregnant woman.  Pituitary. 2002;  5 99-107
• 5 Caron P, Gerbeau C, Pradayrol L. Maternal-fetal transfer of octreotide.  N Engl J Med. 1995;  333 601-602
• 6 Colao A, Merola B, Ferone D, Lombardi G. Acromegaly.  J Clin Endocrinol Metab. 1997;  82 2777-2781
• 7 Cundy T, Grundy E N, Melville H, Sheldon J. Bromocriptine treatment of acromegaly following spontaneous conception.  Fertil Steril. 1984;  42 134-136
• 8 de Menis E, Billeci D, Marton E, Gussoni G. Uneventful pregnancy in an acromegalic patient treated with slow-release lanreotide: a case report.  J Clin Endocrinol Metab. 1999;  84 1489
• 9 Fassnacht M, Capeller B, Arlt W, Steck T, Allolio B. Octreotide LAR® treatment throughout pregnancy in an acromegalic woman.  Clin Endocrinol. 2001;  55 411-415
• 10 Herman-Bonert V, Seliverstov M, Melmed S. Pregnancy in acromegaly: successful therapeutic outcome.  J Clin Endocrinol Metab. 1998;  83 727-731
• 11 Hierl T, Ziegler R, Kasperk C. Pregnancy in persistent acromegaly.  Clin Endocrinol. 2000;  53 262-263
• 12 Kupersmith M J, Rosenberg C, Kleinberg D. Visual loss in pregnant women with pituitary adenomas.  Ann Intern Med. 1994;  121 473-477
• 13 Landolt A M, Schmid J, Wimpfheimer C, Karlsson E RC, Boerlin V. Successful pregnancy in a previously infertile woman treated with SMS‐201-995 for acromegaly.  N Engl J Med. 1989;  320 671-672
• 14 Lunardi P, Rizzo A, Missori P, Fraioli B. Pituitary apoplexy in an acromegalic woman operated on during pregnancy by transsphenoidal approach.  Int J Gynecol Obstet. 1990;  34 71-74
• 15 Mikhail N. Octreotide treatment of acromegaly during pregnancy.  Mayo Clin Proc. 2002;  77 297-298
• 16 Molitch M E. Pituitary tumors and pregnancy.  Growth Horm IGF Res. 2003;  13 S38-S44
• 17 Montini M, Pagani G, Gianola D, Pagani M D, Piolini R, Camboni M G. Acromegaly and primary amenorrhea: ovulation and pregnancy induced by SMS-201-995 and bromocriptine.  J Endocrinol Invest. 1990;  13 193
• 18 Mozas J, Ocón E, de la Torre M L, Suárez A M, Miranda J A, Herruzo A J. Successful pregnancy in a woman with acromegaly treated with somatostatin analog (octreotide) prior to surgical resection.  Int J Gynecol Obstet. 1999;  65 71-73
• 19 Okada Y, Morimoto I, Ejima K, Yoshida K, Kashimura M, Fujihira T, Eto S. A case of active acromegalic woman with a marked increase in serum insulin-like growth factor-1 levels after delivery.  Endocr J. 1997;  44 117-120
• 20 Takeuchi K, Funakoshi T, Oomori S, Maruo T. Successful pregnancy in an acromegalic woman treated with octreotide.  Obstet Gynecol. 1999;  93 848
• 21 Yap A S, Clouston W M, Mortimer R H, Drake R F. Acromegaly first diagnosed in pregnancy: role of bromocriptine therapy.  Am J Obstet Gynecol. 1990;  163 477-478